Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19

Objective: The main goal of this study was to assess the potential clinical impact of an outpatient administration of available antivirals including SOT, N/R, and MOL to COVID-19 patients at high risk for disease progression. Methods: We conducted a retrospective analysis on 2606 outpatient individu...

Full description

Bibliographic Details
Published in:Viruses
Main Authors: Victoria Kauer, David Totschnig, Ferdinand Waldenberger, Max Augustin, Mario Karolyi, Michelle Nägeli, Christoph Wenisch, Alexander Zoufaly
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Subjects:
COVID-19
SARS-CoV-2
coronavirus
antiviral therapy
outpatient treatment
sotrovimab
Online Access:https://www.mdpi.com/1999-4915/15/5/1181

Internet

https://www.mdpi.com/1999-4915/15/5/1181

Similar Items